The investment project of the CABIO R&D Centre officially commenced on 19 October in Wuhan Optical Valley. Upon the basis of the said investment project, the ground-breaking ceremony of the Wuhan Synthetic Biology Innovation Center project, a joint endeavor between CABIO Biotech (Wuhan), the Wuhan Institute of Industrial Innovation and Development and Hubei Yangtze Science Innovation Service, was also held on the same day.

It aims to expand the application scope of synthetic biology technologies effectively, promote the standardization of the industry, raise research achievement transformation efficiency, build complete synthetic biology scientific and technological innovation and industry transformation systems, and establish itself as an internationally top-notch and domestically leading innovation center dedicated to the advancement of the synthetic biology industry.

The centre will further propel Wuhan toward its goal of developing its world-class, trillion-yuan-scale greater health industry cluster, bolster the high-quality development of Hubei Province's biology industry, and advance the internationalization effort and progress of Chinese synthetic biology technologies.

During the ground-breaking ceremony of the innovation centre, CABIO also officially unveiled its brand new synthetic biology-based product line: HMOs series, lipid nutrient series, high value-added personal care ingredients, and so forth. In the future, CABIO will continue to roll out brand new products armed with synthetic biology-based disruptive technology.